esin, e. Et Al. 2018. Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naïve breast cancer: real-life practice outcomes.. Cancer Chemotherapy And Pharmacology .

esin, e., ÇAKMAK ÖKSÜZOĞLU, Ö. B., BİLİCİ, A., ÇİÇİN, İ., KÖSTEK, O., KAPLAN, M. A., ... AKSOY, S.(2018). Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naïve breast cancer: real-life practice outcomes.. Cancer Chemotherapy And Pharmacology .

esin, ece Et Al. "Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naïve breast cancer: real-life practice outcomes.," Cancer Chemotherapy And Pharmacology , 2018

esin, ece Et Al. "Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naïve breast cancer: real-life practice outcomes.." Cancer Chemotherapy And Pharmacology , 2018

esin, e. Et Al. (2018) . "Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naïve breast cancer: real-life practice outcomes.." Cancer Chemotherapy And Pharmacology .

@article{article, author={ece esin Et Al. }, title={Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naïve breast cancer: real-life practice outcomes.}, journal={Cancer Chemotherapy And Pharmacology}, year=2018}